PAEA Surgery End Of Rotation (EOR) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the PAEA Surgery EOR Exam with comprehensive quizzes and questions. Challenge yourself with multiple-choice questions, insights, and detailed explanations. Get exam-ready with us!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


What type of carcinoma is most often seen in bladder cancer cases?

  1. Adenocarcinoma

  2. Sarcoma

  3. Transitional cell carcinoma

  4. Squamous cell carcinoma

The correct answer is: Transitional cell carcinoma

Transitional cell carcinoma, also known as urothelial carcinoma, is the most common type of carcinoma associated with bladder cancer. This type of cancer originates in the urothelial cells that line the bladder, which are specifically designed to handle the high-pressure environment of urine storage. Transitional cell carcinoma accounts for approximately 90% of all bladder cancer cases, making it the predominant histological type. Understanding the significance of transitional cell carcinoma in bladder cancer is essential for effective diagnosis and treatment. The presentation of this type of cancer can vary, and it can appear as superficial lesions or invasive tumors. The recognition of this carcinoma as the most prevalent form can guide clinicians in both management strategies and patient education regarding risk factors, symptoms, and potential outcomes. In contrast, adenocarcinoma, sarcoma, and squamous cell carcinoma represent much rarer forms of bladder cancer. Adenocarcinoma arises from glandular cells and is less common in the bladder, while sarcoma originates from connective tissues and is extremely rare. Squamous cell carcinoma typically develops in response to chronic irritation or infection, such as that caused by schistosomiasis in certain endemic regions, but again, it is significantly less prevalent than transitional cell carcinoma. Understanding the variety and frequency of these different